Safety of gadolinium contrast agent in hemodialysis patients

Acta Radiologica

Volumn 42, Issue 3, 2001, Pages 339-341

  Okada, Susumu ^a   Katagiri, K ^b   Kumazaki, T ^b   Yokoyama, H ^c  

^a NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c Department of Urology   (Japan)

Author keywords

Contrast agent, gadolinium; Renal failure, hemodialysis

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0035324584     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418501127346756     Document Type: Article

References (12)

1. CHOYKE P. L., FRANK J. A., WEBB D. & FILLING-KATZ M. R.: Case report. Gadopentetate dimeglumine enhanced MRI in an anephric patient on dialysis. Clin. Radiol. 41 (1990), 430.
2. CHOYKE P. L., GIRTON M. E., VAUGHAN E. M., FRANK J. A. & AUSTIN H. A.: Clearance of gadolinium chelates by hemodialysis. An in vitro study. JMRI 4 (1995), 470.
3. GOLDSTEIN E. J., BURNETT K. R., HANSELL J. R. et al.: Gadolinium-DTPA (an NMR proton imaging contrast agent). Chemical structure, paramagnetic properties and pharmacokinetics. Physiol. Chem. Phys. Med. NMR 16 (1984), 97.
4. HAUSTEIN J., NIENDORF H. P., KRESTIN G. et al.: Renal tolerance of gadolinium DTPA/dimeglumine in patients with chronic renal failure. Invest. Radiol. 27 (1992), 153.
5. HAUSTEIN J., NIENDORF H. P. & LOUTON T.: Renal tolerance of Gd-DTPA - A retrospective evaluation of 1171 patients. Magn. Reson. Imaging 8 (1990), 43.
6. HAUSTEIN J. & SCHUHMANN-GIAMPIERI G.: Elimination of Gd-DTPA by means of hemodialysis. Eur. J. Radiol. 11 (1990), 227.
7. JEFFE P., THOMSEN H. S. & MEUSEL M.: Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis. Acad. Radiol. 5 (1998), 491.
8. KRAHE V. T., GOTZ R., LACKNER K. et al.: Pharmakokinetik von gadolinium-DTPA bei dialysepflichtiger chronischer Niereninsuffizienz. RÖFO 156 (1992), 523.
9. MAISONNEUVE P., AGODOA L., GELLERT R. et al.: Cancer in patients on dialysis for end-stage renal disease. An international collaborative study. Lancet 354 (1999), 93.
10. SCHUHMANN-GIAMPIERI G., CLAUSS W. & KRESTIN G. P.: Pharmakokinetics of Gd-DTPA in patients with chronic renal failure. Invest. Radiol. 26 (1991), 975.
11. WEINMANN H. J., BRASCH R. C., PRESS W. R. & WESBEY G. E.: Characteristics of gadolinium-DTPA complex. A potential NMR contrast agent. AJR 142 (1984), 619.
12. WEINMANN H. J., LANIADO M. & MUTZEL W.: Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol. Chem. Phys. Med. NMR 16 (1984), 167.